CGMO Mesa Meeting — Cell and Gene Therapy Conference

On October 6, 2023, the Meeting on the Mesa agenda included SmartLabs among the companies presenting new approaches to cell and gene therapy R&D. My session focused on how scalable infrastructure and cross-disciplinary design can accelerate commercialization of next-generation therapies.

The event brought together leaders from biotech, finance, and manufacturing to discuss the future of advanced modalities — highlighting SmartLabs’ role in building the platforms that make them possible.

View the agenda → Meeting on the Mesa